These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 441510

  • 1. Amino acid conferred protection against melphalan: comparison of amino acids which reduce melphalan toxicity to murine bone marrow precursor cells (CFU-C) and murine L1210 leukemia cells.
    Vistica DT, Rabon A, Rabinovitz M.
    Res Commun Chem Pathol Pharmacol; 1979 Jan; 23(1):171-83. PubMed ID: 441510
    [Abstract] [Full Text] [Related]

  • 2. Amino acid-conferred resistance to melphalan. I. Structure-activity relationship in cultured murine L1210 leukemia cells.
    Vistica DT, Toal JN, Rabinovitz M.
    Cancer Treat Rep; 1976 Sep; 60(9):1363-7. PubMed ID: 1016969
    [Abstract] [Full Text] [Related]

  • 3. Amino acid conferred protection against melphalan: interference with leucine protection of melphalan cytotoxicity by the basic amino acids in cultured murine L1210 leukemia cells.
    Vistica DT, Toal JN, Rabinovitz M.
    Mol Pharmacol; 1978 Nov; 14(6):1136-42. PubMed ID: 732811
    [No Abstract] [Full Text] [Related]

  • 4. Antitumor activity and bone marrow toxicity of aminoglucose mustard anticancer agents in mice.
    Cantrell JE, Green D, Schein PS.
    Cancer Res; 1986 May; 46(5):2340-3. PubMed ID: 2938728
    [Abstract] [Full Text] [Related]

  • 5. Amino acid-conferred protection against melphalan--characterization of melphalan transport and correlation of uptake with cytotoxicity in cultured L1210 murine leukemia cells.
    Vistica DT, Toal JN, Rabinovitz M.
    Biochem Pharmacol; 1978 May; 27(24):2865-70. PubMed ID: 736979
    [No Abstract] [Full Text] [Related]

  • 6. Role of cytoprotective mechanisms in the photochemical purging of autologous bone marrow grafts.
    Yamazaki T, Sato Y, Sieber F.
    Exp Hematol; 1997 Jul; 25(7):629-37. PubMed ID: 9216739
    [Abstract] [Full Text] [Related]

  • 7. Chemosensitization of L-phenylalanine mustard by the thiol-modulating agent buthionine sulfoximine.
    Kramer RA, Greene K, Ahmad S, Vistica DT.
    Cancer Res; 1987 Mar 15; 47(6):1593-7. PubMed ID: 3815359
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Combinations of 4-hydroperoxycyclophosphamide (4-HC) and cisplatin for bone marrow purging in autologous marrow transplantation: an update.
    Peters RH, Brandon CS, Avila LA, Gale GR, Stuart RK.
    Prog Clin Biol Res; 1990 Mar 15; 333():57-68. PubMed ID: 2309001
    [Abstract] [Full Text] [Related]

  • 10. Ethanol mustard cytotoxicity in vitro toward murine leukemia and bone marrow progenitor cells.
    Naujokaitis SA, Fisher JM, Rabinovitz M.
    Res Commun Chem Pathol Pharmacol; 1981 Aug 15; 33(2):305-18. PubMed ID: 7302378
    [Abstract] [Full Text] [Related]

  • 11. Biologic effects of prolonged melphalan treatment of murine long-term bone marrow cultures and interleukin 3-dependent hematopoietic progenitor cell lines.
    Greenberger JS, Palaszynski EW, Pierce JH, Sakakeeny MA, Ruscetti SK, Ihle JN, Daugherty C.
    J Natl Cancer Inst; 1985 Jan 15; 74(1):247-62. PubMed ID: 3918212
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. 6-[Bis(2-chloroethyl)amino]-6-deoxygalactopyranose hydrochloride (C6-galactose mustard), a new alkylating agent with reduced bone marrow toxicity.
    Schein PS, Green D, Dean SW, McPherson E.
    Cancer Res; 1987 Feb 01; 47(3):696-9. PubMed ID: 3802075
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparative heat sensitivity of murine and human hemopoietic progenitors and clonogenic leukemia cells.
    Gidáli J, Fehér I, Kovács P.
    Stem Cells; 1994 Sep 01; 12(5):533-8. PubMed ID: 7804126
    [Abstract] [Full Text] [Related]

  • 16. Cain's quinolinium (NSC 176319): protection of murine L1210 leukemia cells and bone marrow progenitor cells against mechlorethamine cytotoxicity and its application to combination chemotherapy.
    Naujokaitis SA.
    Res Commun Chem Pathol Pharmacol; 1981 Oct 01; 34(1):97-104. PubMed ID: 7313308
    [Abstract] [Full Text] [Related]

  • 17. The relative contribution of drug concentration and duration of exposure to mouse bone marrow toxicity during continuous methotrexate infusion.
    Pinedo HM, Zaharko DS, Bull J, Chabner BA.
    Cancer Res; 1977 Feb 01; 37(2):445-50. PubMed ID: 832268
    [Abstract] [Full Text] [Related]

  • 18. In vitro chemoseparation of leukemic cells from murine bone marrow using VP16-213: importance of stem cell assays.
    Stiff PJ, Koester AR.
    Exp Hematol; 1987 Mar 01; 15(3):263-8. PubMed ID: 3545881
    [Abstract] [Full Text] [Related]

  • 19. Effect of methotrexate on murine bone marrow cells in vitro: evidence of a reversible antiproliferative action.
    Strømhaug A, Warren DJ, Slørdal L.
    Exp Hematol; 1995 May 01; 23(5):439-43. PubMed ID: 7720815
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.